Rüschoff J, Friedrich M, Nagelmeier I et al Comparison of HercepTestTM mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status. This evidence concerns the gene ERBB2 and breast carcinoma.